» Articles » PMID: 27424552

Genomics Era and Complex Disorders: Implications of GWAS with Special Reference to Coronary Artery Disease, Type 2 Diabetes Mellitus, and Cancers

Overview
Journal J Postgrad Med
Specialty General Medicine
Date 2016 Jul 19
PMID 27424552
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The Human Genome Project (HGP) has identified millions of single nucleotide polymorphisms (SNPs) and their association with several diseases, apart from successfully characterizing the Mendelian/monogenic diseases. However, the dissection of precise etiology of complex genetic disorders still poses a challenge for human geneticists. This review outlines the landmark results of genome-wide association studies (GWAS) with respect to major complex diseases - Coronary artery disease (CAD), type 2 diabetes mellitus (T2DM), and predominant cancers. A brief account on the current Indian scenario is also given. All the relevant publications till mid-2015 were accessed through web databases such as PubMed and Google. Several databases providing genetic information related to these diseases were tabulated and in particular, the list of the most significant SNPs identified through GWAS was made, which may be useful for designing studies in functional validation. Post-GWAS implications and emerging concepts such as epigenomics and pharmacogenomics were also discussed.

Citing Articles

A Genome-Wide Association Study of Metabolic Syndrome in the Taiwanese Population.

Ho C, Lee J, Huang S, Chen S, Geng J Nutrients. 2024; 16(1).

PMID: 38201907 PMC: 10780952. DOI: 10.3390/nu16010077.


Analysis of 61 SNPs from the CAD specific genomic loci reveals unique set of SNPs as significant markers in the Southern Indian population of Hyderabad.

Gorre M, Rayabarapu P, Battini S, Irgam K, Battini M BMC Cardiovasc Disord. 2022; 22(1):148.

PMID: 35379196 PMC: 8981708. DOI: 10.1186/s12872-022-02562-4.


GWAS in people of Middle Eastern descent reveals a locus protective of kidney function-a cross-sectional study.

Mohamed S, Fernadez-Tajes J, Franks P, Bennet L BMC Med. 2022; 20(1):76.

PMID: 35227251 PMC: 8886846. DOI: 10.1186/s12916-022-02267-7.


Polymorphisms Are Associated with Increased Risk of Developing Premature Coronary Artery Disease and with Some Cardiometabolic Parameters: The GEA Mexican Study.

Posadas-Sanchez R, Roque-Ramirez B, Rodriguez-Perez J, Perez-Hernandez N, Fragoso J, Villarreal-Molina T Mediators Inflamm. 2019; 2018:1847696.

PMID: 30662365 PMC: 6312582. DOI: 10.1155/2018/1847696.


Variants in the gene was associated with coronary artery disease susceptibility in Chinese Han population.

Zhang J, Ma H, Gao J, Kong S, You J, Sheng Y Oncotarget. 2017; 8(33):54518-54527.

PMID: 28903360 PMC: 5589599. DOI: 10.18632/oncotarget.17171.


References
1.
Silander K, Tang H, Myles S, Jakkula E, Timpson N, Cavalli-Sforza L . Worldwide patterns of haplotype diversity at 9p21.3, a locus associated with type 2 diabetes and coronary heart disease. Genome Med. 2009; 1(5):51. PMC: 2689443. DOI: 10.1186/gm51. View

2.
AshokKumar M, Emmanuel C, Dhandapany P, Rani D, Saibabu R, Cherian K . Haplotypes on 9p21 modify the risk for coronary artery disease among Indians. DNA Cell Biol. 2010; 30(2):105-10. DOI: 10.1089/dna.2010.1046. View

3.
Setia N, Verma I, Khan B, Arora A . Premature coronary artery disease and familial hypercholesterolemia: need for early diagnosis and cascade screening in the Indian population. Cardiol Res Pract. 2011; 2012:658526. PMC: 3205657. DOI: 10.1155/2012/658526. View

4.
Aneesh T P , M S, Jose A, Chandran L, Mary Zachariah S . Pharmacogenomics: the right drug to the right person. J Clin Med Res. 2012; 1(4):191-4. PMC: 3299179. DOI: 10.4021/jocmr2009.08.1255. View

5.
Stratton M, Campbell P, Futreal P . The cancer genome. Nature. 2009; 458(7239):719-24. PMC: 2821689. DOI: 10.1038/nature07943. View